Research | OneLook Acronym Finder |
Serial Number | 87284044 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Law Office Assigned | L60 |
Employee Name | SINGH, TEJBIR |
2016-12-29 | Application Filed |
2017-10-11 | Abandon |
2017-11-06 | Location: TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED |
2017-11-06 | Status: Dead/Abandoned |
2018-07-08 | Transaction Date |
Owner: | Coalesce Medcom, LLC |
Address | 75 Woodlawn Avenue Saratoga Springs NY 12866 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | NY |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Providing website featuring non-downloadable software for the pharmaceutical and biotech industries, namely, software to assist them when selecting Key Opinion Leaders or KOLs (KOL is a term used in this industry to refer to more influential healthcare providers) as a consultant, to participate at advisory meetings, to speak on their behalf, or to provide medical writing support. Pharmaceutical and biotech industries have no current methodology to select KOLs to support their communication offerings beyond selecting them based on hope that the opinion leader will perform to their standards. This software utilizes a 250+ point assessment to more adequately inform the pharmaceutical and biotech industry of the opinion leaders specific experiences with these communication offerings, research interests, and knowledge of the disease state to better inform KOL selection for these activities. The term ENGAUGE was selected because the data for each KOL is shown on a 5 point gauge indicating their level of experience and level of risk when ENGAGING these KOLs to support specific offerings |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2017-01-02 | 1 NWAP I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-01-10 | 2 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2017-03-27 | 3 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2017-04-03 | 4 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2017-04-03 | 5 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-04-03 | 6 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-04-04 | 7 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-04-04 | 8 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-04-05 | 9 TEME I:Incoming Correspondence |
FINAL REFUSAL WRITTEN | 2017-04-10 | 10 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2017-04-10 | 11 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2017-04-10 | 12 GNFN O:Outgoing Correspondence |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2017-11-06 | 13 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | 2017-11-06 | 14 MAB2 O:Outgoing Correspondence |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.